People's Hospital of Tongling City
Tongling, China
Location status: Recruiting
NCT Number: NCT06943781
This is a prospective study designed to compare the performance of fecal H. pylori gastric cancer susceptibility analysis and the gastric cancer risk questionnaire for the early detection of gastric cancer. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo fecal H. pylori gastric cancer susceptibility testing and complete the gastric cancer risk questionnaire.
Interested in participating?
Request Info40 year and older
All sexes
Observational
Tongling, China
Location status: Recruiting
Sample Selection:
The study will be conducted in selected communities within Tongling City, with a total of 10000-15000 residents recruited.
Participants Recruitment:
Tests and Follow-up:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the early stage of the study, the team used genome-wide association analysis (GWAS) to identify H. pylori specific SNP that are significantly associated with gastric cancer in gastric cancer patients and controls; according to the mutation or not of the SNP loci, the strains were categorized into the high-risk group of gastric cancer and the low-risk group. The status of the SNP locus was detected in portable and non-invasive fecal samples from participants using molecular biology assays for early non-invasive screening and risk assessment of gastric cancer in H. pylori infected patients.
Time frame: 2 years
To compare the sensitivity and specificity of fecal H. pylori gastric cancer susceptibility testing and questionnaire screening for gastric cancer.
Time frame: 2 years
To compare the positive and negative predictive values of fecal H. pylori gastric cancer susceptibility testing and questionnaire screening methods for gastric cancer
Time frame: 2 years
To compare the number of participants needed to screen identify one gastric cancer for different methods
Time frame: 2 years
To compare the early gastric cancer detection rate achieved by the fecal H. pylori gastric cancer susceptibility testing and the questionnaire screening.
Contact information is provided by the study sponsor or research team.
Fudan University
Other
Research on the Application of Fecal Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection in the Early Diagnosis and Screening of Gastric Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07277413
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus
Santa Rosa, California, United States
View Trial DetailsNCT07699939
Adenocarcinoma, Carcinoma
Chiba, Japan
View Trial DetailsNCT07673887
Adenocarcinoma, Carcinoma
Dorado, Puerto Rico
View Trial DetailsNCT07282912
Adenocarcinoma, Adenocarcinoma Of Esophagus
New Haven, Connecticut, United States
View Trial Details